NOT FOR DISTRIBUTION
Header cover image

Market Cap

US$12.2b

Last Updated

2021/05/13 04:16 UTC

Data Sources

Company Financials +

Executive Summary

Invesco Ltd. is a publicly owned investment manager. More Details


Snowflake Analysis

Excellent balance sheet established dividend payer.


Similar Companies

Share Price & News

How has Invesco's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: IVZ is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 6% a week.

Volatility Over Time: IVZ's weekly volatility (6%) has been stable over the past year.


Market Performance


7 Day Return

-6.7%

IVZ

-1.8%

US Capital Markets

-2.8%

US Market


1 Year Return

277.3%

IVZ

67.9%

US Capital Markets

49.4%

US Market

Return vs Industry: IVZ exceeded the US Capital Markets industry which returned 67.9% over the past year.

Return vs Market: IVZ exceeded the US Market which returned 49.4% over the past year.


Shareholder returns

IVZIndustryMarket
7 Day-6.7%-1.8%-2.8%
30 Day1.8%1.6%-2.3%
90 Day16.3%8.9%-1.3%
1 Year291.5%277.3%71.6%67.9%51.8%49.4%
3 Year8.8%-8.0%54.4%43.4%57.5%47.6%
5 Year16.5%-8.4%161.2%129.6%121.7%97.1%

Long-Term Price Volatility Vs. Market

How volatile is Invesco's share price compared to the market and industry in the last 5 years?


Simply Wall St News

Valuation

Is Invesco undervalued compared to its fair value and its price relative to the market?

>50%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: IVZ ($26.37) is trading below our estimate of fair value ($60.66)

Significantly Below Fair Value: IVZ is trading below fair value by more than 20%.


Price To Earnings Ratio

PE vs Industry: IVZ is poor value based on its PE Ratio (17.1x) compared to the US Capital Markets industry average (17x).

PE vs Market: IVZ is good value based on its PE Ratio (17.1x) compared to the US market (19.5x).


Price to Earnings Growth Ratio

PEG Ratio: IVZ is poor value based on its PEG Ratio (6.1x)


Price to Book Ratio

PB vs Industry: IVZ is good value based on its PB Ratio (1.2x) compared to the US Capital Markets industry average (68.1x).


Future Growth

How is Invesco forecast to perform in the next 1 to 3 years based on estimates from 13 analysts?

2.8%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: IVZ's forecast earnings growth (2.8% per year) is above the savings rate (2%).

Earnings vs Market: IVZ's earnings (2.8% per year) are forecast to grow slower than the US market (14.7% per year).

High Growth Earnings: IVZ's earnings are forecast to grow, but not significantly.

Revenue vs Market: IVZ's revenue (2% per year) is forecast to grow slower than the US market (9% per year).

High Growth Revenue: IVZ's revenue (2% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: IVZ's Return on Equity is forecast to be low in 3 years time (9.5%).


Past Performance

How has Invesco performed over the past 5 years?

-12.2%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: IVZ has high quality earnings.

Growing Profit Margin: IVZ's current net profit margins (11.5%) are higher than last year (7.2%).


Past Earnings Growth Analysis

Earnings Trend: IVZ's earnings have declined by 12.2% per year over the past 5 years.

Accelerating Growth: IVZ's earnings growth over the past year (51.8%) exceeds its 5-year average (-12.2% per year).

Earnings vs Industry: IVZ earnings growth over the past year (51.8%) exceeded the Capital Markets industry 33%.


Return on Equity

High ROE: IVZ's Return on Equity (6.9%) is considered low.


Financial Health

How is Invesco's financial position?


Financial Position Analysis

Short Term Liabilities: IVZ's short term assets ($16.7B) exceed its short term liabilities ($2.5B).

Long Term Liabilities: IVZ's short term assets ($16.7B) do not cover its long term liabilities ($17.0B).


Debt to Equity History and Analysis

Debt Level: IVZ's debt to equity ratio (11.5%) is considered satisfactory.

Reducing Debt: IVZ's debt to equity ratio has reduced from 24.8% to 11.5% over the past 5 years.

Debt Coverage: IVZ's debt is well covered by operating cash flow (72.6%).

Interest Coverage: IVZ earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Dividend

What is Invesco current dividend yield, its reliability and sustainability?

2.35%

Current Dividend Yield


Dividend Yield vs Market

Notable Dividend: IVZ's dividend (2.35%) is higher than the bottom 25% of dividend payers in the US market (1.28%).

High Dividend: IVZ's dividend (2.35%) is low compared to the top 25% of dividend payers in the US market (3.48%).


Stability and Growth of Payments

Stable Dividend: IVZ's dividends per share have been stable in the past 10 years.

Growing Dividend: IVZ's dividend payments have increased over the past 10 years.


Current Payout to Shareholders

Dividend Coverage: With its reasonably low payout ratio (41.2%), IVZ's dividend payments are well covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: IVZ's dividends in 3 years are forecast to be well covered by earnings (26.6% payout ratio).


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

4.2yrs

Average management tenure


CEO

Marty Flanagan (60 yo)

15.75yrs

Tenure

US$11,747,102

Compensation

Mr. Martin L. Flanagan, CFA, CPA, also known as Marty, is the President, Chief Executive Officer and Director of Invesco Ltd. since August 1, 2005. Previously, Mr. Flanagan served as the Chief Executive Of...


CEO Compensation Analysis

Compensation vs Market: Marty's total compensation ($USD11.75M) is about average for companies of similar size in the US market ($USD11.15M).

Compensation vs Earnings: Marty's compensation has been consistent with company performance over the past year.


Leadership Team

Experienced Management: IVZ's management team is considered experienced (4.2 years average tenure).


Board Members

Experienced Board: IVZ's board of directors are considered experienced (4 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: IVZ insiders have only sold shares in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Invesco Ltd.'s company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Invesco Ltd.
  • Ticker: IVZ
  • Exchange: NYSE
  • Founded: 1935
  • Industry: Asset Management and Custody Banks
  • Sector: Diversified Financials
  • Market Cap: US$12.168b
  • Shares outstanding: 461.45m
  • Website: https://www.invesco.com

Number of Employees


Location

  • Invesco Ltd.
  • Two Peachtree Pointe
  • 1555 Peachtree Street, NE, Suite 1800
  • Atlanta
  • Georgia
  • 30309
  • United States

Listings


Biography

Invesco Ltd. is a publicly owned investment manager. The firm provides its services to retail clients, institutional clients, high-net worth clients, public entities, corporations, unions, non-profit organ...


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/05/13 04:16
End of Day Share Price2021/05/12 00:00
Earnings2021/03/31
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.